For any further information
Media
Papers QMR Technology
Papers REXON-EYE
Press release
Video
In-vitro analysis of Quantum Molecular Resonance effects on human mesenchymal stromal cells.
S. Sella, V. Adami, E. Amati, M. Bernardi, K. Chieregato, P. Gatto P, et al. PLoS ONE 2018 13 (1): e0190082.Biophysical effects of high frequency electrical field (4-64 MHz) on muscle fibers in culture
Dal Maschio M, Canato M, Pigozzo FM, et al. Biophysical effects of high frequency electrical field (4–64 MHz) on muscle fibers in culture. Basic Applied Myology 2009; 19:49–56.Favorable Tissue Effects of Quantum Molecular Resonance Device (Vesalius®) Compared with Standard Electrocautery
Schiavon M, Calabrese F, Nicotra S, et al. Favorable tissue effects of quantum molecular resonance device (VESALIUS®) compared with standard electrocautery: a novel paradigm in lung surgery. Eur Surg Res 2007; 39:222–8.Quantum molecular resonance technology in hard-to-heal extremity wounds: histological and clinical results.
M. Fraccalvieri, M. Salomone, C. Di Santo, E. Ruka U. Morozzo, S. Bruschi S. Int Wound J 2017; 14:1313–1322.Transcutaneous periorbital electrical stimulation in the treatment of dry eye.
E. Pedrotti, F. Bosello, A. Fasolo, A.C. Frigo, I. Marchesoni, A. Ruggeri, G. Marchini. Br J Ophthalmol 2017, 101:814-9.Innovative radiofrequency electrotherapy significantly reduces cornea perforation in an alkali burn murine model
A. Ruggeri, T. Dyrdin, M. Barbariga, P. Rama, G. Ferrari. Proc. ARVO 2018 Annual Meeting, 2018.High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction
G. Ferrari, A. Colucci, M. Barbariga, A. Ruggeri, P. Rama. Cornea: July 23, 2019Mixed dry eye patients successfully treated by the innovative high-frequency electrotherapy device Rexon-Eye®
A.Ruggeri, E.Fatigati, L.Vigo. ARVO 2020 Annual Meeting, June 2020Improvement in mixed-type dry eye patients after treatment with the QMR®-based electrotherapy device Rexon-Eye®
A. Ruggeri , A.Trivli , G. Dalianis , C. Terzidou. ARVO 2021 Annual Meeting, May 2021
New Zealand – Journal article on Rexon-Eye
In its April 2020 issue "New Zealand Optics" offers its readers an interesting highlighting about...
Editorial on Rexon-Eye
A remarkable interest was raised by the editorial published a few days ago in the Giornale di...
Resono who we are
How Rexon-Eye works
Rexon-Eye first tutorial by Resono
Luca Vigo, head of Dry Eye Center (CARONES Vision) about Rexon-Eye device
Interview with Alfredo Ruggeri, Chairman of Resono Ophthalmic company
Lecture " Rexon-Eye: the reinvented dry eye treatment" at ESCRS 2019, Paris - Part 1
Lecture "Rexon-Eye: the reinvented dry eye treatment" at ESCRS 2019, Paris - Part 2
Watch out to the quarantine effects! Talk with Dr. Luca Vigo, Ophthalmologist. Part 1
Watch out to the quarantine effects! Talk with Dr. Luca Vigo, Ophthalmologist. Part 2
Watch out to the quarantine effects! Talk with Dr. Luca Vigo, Ophthalmologist. Part 3
ARVO 2020 Virtual meeting Presentation - A. Ruggeri
ARVO 2021 Virtual Meeting Presentation - A. Ruggeri
Rexon-Eye presentation at MEOM 2021
REXON EYE Vietnam webinar 2021 07 23